Phocas Financial Corp. Mirum Pharmaceuticals, Inc. Transaction History
Phocas Financial Corp.
- $749 Billion
- Q4 2024
A detailed history of Phocas Financial Corp. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Phocas Financial Corp. holds 37,585 shares of MIRM stock, worth $1.68 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
37,585
Previous 5,699
559.5%
Holding current value
$1.68 Million
Previous $236 Million
559.44%
% of portfolio
0.21%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$293 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$205 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$145 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$125 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$116 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...